Magis Pharma Group

Antwerpen ·KBO/BCE: BE 0765.834.004

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	8.3%	44.9%	better than 16% of 678 sector peers
Net result	€-9.44M	€48k	better than 5% of 677 sector peers
Equity	€929k	€1.36M	better than 46% of 678 sector peers
Total assets	€11.18M	€5.58M	better than 60% of 678 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€11.18M
Fixed assets	21/28	€5.41M
Intangible fixed assets	21	€35k
Financial fixed assets	28	€5.37M
Current assets	29/58	€5.77M
Stocks & contracts in progress	3	€0
Amounts receivable within one year	40/41	€3.92M
Cash & bank	54/58	€85k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€11.18M
Equity	10/15	€929k
Contributions / capital	10/11	€10.25M
Accumulated profits (losses)	14	€-9.35M
Amounts payable	17/49	€10.25M
Amounts payable after one year	17	€8.38M
Amounts payable within one year	42/48	€1.64M
Trade debts payable within one year	44	€843k
Income statement
Turnover	70	€865k
Operating result	9901	€-9.56M
Financial income	75	€567k
Financial charges	65	€444k
Result before taxes	9903	€-9.44M
Net result for the period	9904	€-9.44M
Result to be appropriated	9905	€-9.44M

Statutory auditor	IRE/IBR number	Tenure
NV Callens VandelanotteCurrent Statutory auditor · represented by Mathias Roef	-	26-11-2025 → present
Vandelanotte Bedrijfsrevisoren Company auditor · represented by Filip REMMERY succeeded by NV Callens Vandelanotte in 2025	-	16-04-2021 → 26-11-2025

Summary